HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA antimicrobials review

This article was originally published in The Rose Sheet

Executive Summary

May 11 meeting of the Anti-Infective Drugs Advisory Committee is cancelled. The committee was to discuss microbiologic endpoints as surrogates for efficacy in clinical trials designed to address the safety and efficacy of antiseptic health care drug products, which could impact OTC antimicrobials. Cosmetic, Toiletry and Fragrance Association and Soap and Detergent Association have urged the agency to use their proposed test methods to evaluate efficacy of finished topical antimicrobials in the OTC Antiseptic Health Care Final Monograph...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel